Back to User profile » Mr James Brockbank
Papers published by Mr James Brockbank:
Corrigendum
Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [Corrigendum]
Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyagüez I, Brockbank J, Iglesias T, Llinares J, Sierra J
ClinicoEconomics and Outcomes Research 2021, 13:645-646
Published Date: 14 July 2021
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain
Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyagüez I, Brockbank J, Iglesias T, Llinares J, Sierra J
ClinicoEconomics and Outcomes Research 2021, 13:263-277
Published Date: 22 April 2021